Physician profile
Christopher Johnson
NPI 1992191746
$32,638.18
in general payments reported to CMS, 2019-2025
18 companies · $253 in 2025
The $253 reported for 2025 was less than what a typical Trauma Surgery provider received nationally (typical 2025 total: $294).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $18.74 · 2020: $218 · 2021: $601 · 2022: $18K · 2023: $11K · 2024: $2,856 · 2025: $253.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Education: $9,000 · Food and Beverage: $2,732 · Travel and Lodging: $1,740 · Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $500.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Education | $9,000.00 |
| Food and Beverage | $2,732.46 |
| Travel and Lodging | $1,740.34 |
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $500.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $28,419.38 | 2019-2024 | Da Vinci Surgical System, Davinci Xi, Da Vinci Sp |
| W. L. Gore & Associates, INC. | $1,594.19 | 2021-2025 | Gore Synecor Biomaterial, Gore Enform Preperitoneal Biomaterial |
| Enterra Medical, INC. | $1,402.47 | 2023-2024 | |
| Davol INC. | $268.10 | 2021-2022 | |
| Medtronic, INC. | $157.47 | 2021-2025 | Endoflip |
| Ethicon US, LLC | $153.61 | 2020-2021 | |
| Tela Bio, INC. | $145.95 | 2024 | Ovitex 2s |
| Endogastric Solutions, INC | $130.30 | 2021 | |
| Next Science LLC | $82.50 | 2020 | |
| Baxter Healthcare | $79.25 | 2023 | Renal - Pd |
| Ambu INC. | $56.85 | 2023 | |
| Medical Device Business Services, INC. | $39.16 | 2024 | Linx Reflux Management System |
| Lucid Diagnostics INC. | $33.02 | 2024 | |
| Smith+Nephew, INC. | $20.11 | 2025 | Collagenase Santyl |
| Genzyme Corporation | $14.78 | 2021 |
Show all 18 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Acacia Pharma INC | $14.59 | 2021 | |
| Myriad Genetic Laboratories, INC. | $13.52 | 2025 | Myrisk |
| Pacira Pharmaceuticals Incorporated | $12.93 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Christopher Johnson listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.